Related Experiment Video

Updated: May 11, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
09:33

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

Carotid artery intima-media thickness and the renin-angiotensin system

Christopher T Johnson1, Luke P Brewster

  • 1Emory University School of Medicine, Atlanta, GA30322, USA.

Hospital Practice (1995)
|May 18, 2013
PubMed

Insights

Carotid artery intima-media thickness (IMT) reduction may be influenced by angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs). This review updates understanding of their role in improving arterial health and cardiovascular disease outcomes.

Area of Science:

  • Cardiovascular medicine
  • Pharmacology
  • Vascular biology

Background:

  • Carotid artery intima-media thickness (IMT) serves as a key biomarker for cardiovascular disease risk.
  • Hypertension management is crucial for cardiovascular health.
  • Angiotensin-converting enzyme (ACE) inhibition offers dual benefits for hypertension and arterial health.

Purpose of the Study:

  • To review the current evidence on the role of ACE inhibitors and angiotensin receptor blockers (ARBs) in reducing carotid artery IMT.
  • To clarify the therapeutic potential of these agents in improving vascular health and cardiovascular outcomes.

Main Methods:

  • Literature review of studies investigating ACE inhibitors and ARBs effects on IMT.
  • Analysis of clinical trial data and observational studies.
  • Synthesis of evidence regarding mechanisms of action on arterial wall.

Main Results:

  • ACE inhibitors and ARBs have demonstrated potential in decreasing IMT in various patient populations.
  • Evidence suggests these drug classes may improve arterial health beyond blood pressure reduction.
  • Further research is ongoing to fully elucidate their impact on cardiovascular mortality.

Conclusions:

  • ACE inhibitors and ARBs may play a significant role in IMT regression.
  • These agents represent a valuable therapeutic strategy for managing cardiovascular disease risk.
  • Understanding their vascular effects is critical for optimizing treatment protocols.

More Related Videos

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...